# Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome

> **NCT01511016** · NA · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 17 (actual)

## Conditions studied

- HIV Lipodystrophy

## Interventions

- **DRUG:** Human recombinant leptin ("metreleptin")
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01511016
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** 2011-06
- **Final completion:** 2011-10
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2016-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01511016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01511016, "Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01511016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*